Business
With Biogen’s multiple sclerosis portfolio facing more generic pressure than ever, the company is eyeing a busy late-stage pipeline and hunting for deals to build its return to growth.
FEATURED STORIES
Analysts parsed the limited data available for Pfizer’s obesity candidate on the pharma’s fourth-quarter earnings call Tuesday, looking for any nugget of additional context.
After advancing in lockstep through the pandemic, the fortunes of the biotechs have diverged as their use of COVID-19 windfalls has taken shape.
After suffering in the wake of expired tax incentives for pharmas, the island is trying to take advantage of geopolitics to grow its drug manufacturing sector.
Subscribe to BioPharm Executive
Market insights and trending stories for biopharma leaders, in your inbox every Wednesday
THE LATEST
As the 61st American Society of Hematology Annual Meeting wrapped up in Orlando, Florida, there were hundreds of studies and results presented. Here’s a look at some.
Proteona Pte. Ltd. has announced the results of the firstProteona Oncology Challenge, co-sponsored by NovogeneAIT.
Scilligence, an innovation leader of unified informatics platform for biologics and small molecules drug R&D, has partnered with Certara to enable advanced data analysis and visualization capabilities.
Similar to the Biotech Bay list, BioSpace takes a look at the top 10 2019 Life Sciences Ideal Employer Report’s for Genetown.
AbbVie and Scripps Research Enter Research Partnership in Cancer, Immunology, Neurology and Fibrosis
Under the terms of the deal, Scripps will run preclinical R&D, and in some cases, Phase I clinical trials. AbbVie will have an exclusive option to continue development and possible commercialization activities.
Shares of Alexion Pharmaceuticals have jumped nearly 5% after the company’s board of directors rejected a push for a sale of the company from one of its largest stakeholders, U.K.-based Elliott Advisors, Ltd.
Veritas Genetics was offering whole-genome sequencing for about $600, going head-to-head with companies like 23andMe and Ancestry.com. Earlier this week there were reports the company laid off 50 staffers and now they’ve announced they are ending operations in the U.S.
Researchers from Regenstrief Institute and Indiana University are building and expanding global relationships and collaborations in the fields of public health and health informatics.
Inceptua announced that Paul Wituschek has been appointed President North America.
MC Services AG, a leading international public relations and investor relations firm, announced today that it will be, for the first time, a media partner for Biotech ShowcaseTM.